干眼症

International Dry Eye Workshop. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:75-93.

• 全文
• 摘要

International Dry Eye Workshop. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93-107.

• 全文
• 摘要

Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405-412.

• 全文
• 摘要

International Dry Eye Workshop. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:108-152.

• 全文
• 摘要

International Dry Eye Workshop. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:163-178.

• 全文
• 摘要

1.  International Dry Eye Workshop. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:75-93.

• 全文
• 摘要

2.  International Dry Eye Workshop. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93-107.

• 全文
• 摘要

3.  Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.

• 摘要

4.  Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264-1268.

• 摘要

5.  Damato BE, Allan D, Murray SB, et al. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol. 1984;68:674-680.

• 全文
• 摘要

6.  Chia EM, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol. 2003;31:229-232.

• 摘要

7.  Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86:1347-1351.

• 全文
• 摘要

8.  Latkany R. Dry eyes: etiology and management. Curr Opin Ophthalmol. 2008;19:287-291.

• 摘要

9.  Perry HD. Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care. 2008;14(suppl):S79-S87.

• 全文
• 摘要

10.  Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405-412.

• 全文
• 摘要

11.  Tamer C, Melek IM, Duman T, et al. Tear film tests in Parkinson's disease patients. Ophthalmology. 2005;112:1795.

• 摘要

12.  Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci. 2006;47:1319-1328.

• 全文
• 摘要

13.  Goebbels M. Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol. 2000;84:19-21.

• 全文
• 摘要

14.  Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci. 2002;966:211-222.

• 摘要

15.  Schaumberg DA, Buring JE, Sullivan DA, et al. Hormone replacement therapy and dry eye syndrome. JAMA. 2001;286:2114-2119.

• 全文
• 摘要

16.  Kovacs L, Feher E, Bodnar I, et al. Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjogren's syndrome. Clin Immunol. 2008;128:269-276.

• 摘要

17.  Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013;11:246-258.

• 全文
• 摘要

18.  Jacobi C, Wenkel H, Jacobi A, et al. Hepatitis C and ocular surface disease. Am J Ophthalmol. 2007;144:705-711.

• 摘要

19.  Chronister CL. Review of external ocular disease associated with aids and HIV infection. Optom Vis Sci. 1996;73:225-230.

• 摘要

20.  Ogawa Y, Okamoto S, Wakui M, et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol. 1999;83:1125-1130.

• 全文
• 摘要

21.  Quinto GG, Camacho W, Behrens A. Postrefractive surgery dry eye. Curr Opin Ophthalmol. 2008;19:335-341.

• 摘要

22.  Feng YF, Yu JG, Shi JL, et al. Meta analysis of randomized controlled clinical trial in the effect of hinge location on dry eye syndrome after LASIK. Zhonghua Shiyan Yanke Zazhi/Chinese Journal of Experimental Ophthalmology. 2012;30:847-852.

23.  Prabhakaran VC, Saeed P, Esmaeli B, et al. Orbital and adnexal sarcoidosis. Arch Ophthalmol. 2007;125:1657-1662.

• 全文
• 摘要

24.  Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol. 2008;146:350-356.

• 摘要

25.  Schein O, Tielsch J, Munoz B, et al. Relation between signs and symptoms of dry eye in the elderly. Ophthalmology. 1997;104:1395-1400.

• 摘要

26.  International Dry Eye Workshop. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:108-152.

• 全文
• 摘要

27.  International Dry Eye Workshop. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:163-178.

• 全文
• 摘要

28.  Pucker AD, Ng SM, Nichols JJ. Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Syst Rev. 2016;(2):CD009729.

• 全文
• 摘要

29.  Shine WE, McCulley JP, Pandya AG. Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res. 2003;76;417-420.

• 摘要

30.  Solomon A, Rosenblatt M, Li D, et al. Doxcycline inhibition f IL-1 in the corneal epithelium. Invest Ophthalmol Vis Sci. 2000;41:2544-2557.

• 全文
• 摘要

31.  Tamago RJ, Bok RA, Brem H. Angiogenesis inhibition by minocycline. Cancer Res. 1991;51:672-675.

• 全文
• 摘要

32.  Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004;137:337-342.

• 摘要

33.  Tost FH, Geerling G. Plugs for occlusion of the lacrimal drainage system. Dev Ophthalmol. 2008;41:193-212.

• 摘要

34.  Tuberville AW, Frederick WR, Wood TO. Punctal occlusion in tear deficiency syndromes. Ophthalmology 1982;89:1170-1172.

• 摘要

35.  Ervin AM, Wojciechowski R, Schein O. Punctal occlusion for dry eye syndrome. Cochrane Database Syst Rev. 2010;(9):CD006775.

• 全文
• 摘要

36.  Tsubota K. The effect of wearing spectacles on the humidity of the eye. Am J Ophthalmol. 1989;15;108:92-93.

• 摘要

37.  Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol. 1999;83:390-395.

• 全文
• 摘要

38.  Pan Q, Angelina A, Zambrano A, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2013;(8):CD009327.

• 全文
• 摘要

39.  Geerling G, Tost FH. Surgical occlusion of the lacrimal drainage system. Dev Ophthalmol. 2008;41:213-229.

• 摘要

40.  Yoo SE, Lee DC, Chang MH. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol. 2005;19:258-263.

• 摘要

41.  Tsifetaki N, Kitsos G, Paschides CA, et al. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren's syndrome: a randomized 12 week study. Ann Rheum Dis. 2003;62:1204-1207.

• 全文
• 摘要

42.  Kaswan RL, Salisbury MA, Ward DA. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. Arch Ophthalmol. 1989;107:1210-1216.

• 摘要

43.  Barbino S, Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 2003;22:97-101.

• 摘要

44.  Geerling G, Sieg P. Transplantation of the major salivary glands. Dev Ophthalmol. 2008;41:255-268.

• 摘要

45.  Erdurmus M, Totan Y. Subconjunctival bevacizumab for corneal neovascularization. Graefe's Arch Clin Exp Ophthalmol. 2007;245:1577-1579.

• 摘要

46.  Lekhanont K, Park CY, Combs JC, et al. Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye. J Ocul Pharm Thera. 2007;23:83-88.

• 摘要

47.  Liew SH, Nichols KK, Klamerus KJ, et al. Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial. Ophthalmology. 2012;119:1328-1335.

• 摘要

48.  Semba CP, Torkildsen GL, Lonsdale JD, et al. A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye. Am J Ophthalmol. 2012;153:1050-1060.e1.

• 摘要

49.  American Academy of Ophthalmology Cornea/External Disease Panel, Preferred Practice Patterns Committee. Dry eye syndrome. San Francisco, CA: American Academy of Ophthalmology (AAO); 2013.

• 全文

50.  Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328:584.

• 摘要